Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Valeo Pharma Inc T.VPH

Alternate Symbol(s):  T.VPH.DB | VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

TSX:VPH - Post Discussion

Valeo Pharma Inc > Future thoughts
View:
Post by CanadianJrs on Oct 13, 2021 3:50pm

Future thoughts

Wondering what everyone's 5 year outlook is share price wise on this little lady. Has anyone asked management what their thoughts are on dividends in the future? That and if there's a planned up listing to the TSXV or TSX after we meet break even profitability or net positive?
Comment by kooter33 on Oct 14, 2021 5:55pm
5 year plan?  4 year plan 2025,,,,, 118M shares O/S FD, Revenues by 2024 projected to be $ 160M based on current product portfolio.  Generally you can expect between 6X to 9X sales ( from IR), therefore MC at 6X = $160M x 6/118M shares = $8.13/share.  MC @ 9X sales = $ 160M x 9/118M = $12.20/share. Management expects to add new products to the portfolio thus the $160M revenue per ...more  
Valeo Pharma Inc